Use of female controlled microbicidal products for HIV risk reduction.
Many over-the-counter microbicidal contraceptive methods reduce the risk of acquiring sexually transmitted diseases. This pilot project compared the use of female controlled barrier methods in an extremely high-risk population of low-income drug abusing women following an intervention designed to promote HIV risk reduction and barrier use. An HIV transmission risk reduction interactive intervention emphasizing self-esteem, assertiveness and sexual negotiation was offered to 41 drug dependent women. Participants were randomly assigned to one of two conditions, a male and female condom condition or a male and female condom plus N-9 products (vaginal suppositories, film, gel) condition. Results from the three-month follow-up period suggest that there may be a synergistic effect of availability of multiple protective methods on the overall rate of protective behaviours. The use of the male condom for penile/vaginal sex increased from 19% at study entry to 27% during the three-month follow-up period. The total protected sexual episode rate, calculated to include use of the other protective barriers distributed, was 60%. Thus, the condom use rate was not found to decrease because of the availability of alternative methods of protection. Future research should address the use of microbicidal products to empower women to prevent STD/HIV transmission.
Malow
R M
RM
University of Miami, School of Medicine/JMH Mental Health/Hospital Centers, Department of Psychiatry and Behavioral Sciences, Health Promotion Programs, 1695 N.W. 9 Avenue, Suite 3208, Miami, Florida 33136, USA. RMALOW@Bellsouth.net
Ziskind
D
D
Jones
D L
DL
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D017280:Condoms / Q000706:statistics & numerical data*; D019111:Single-Use Internal Condom / Q000706:statistics & numerical data*; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000517:prevention & control; D006801:Humans; D004366:Nonprescription Drugs / Q000008:administration & dosage; D010570:Pessaries / Q000706:statistics & numerical data; D010865:Pilot Projects; D021841:Safe Sex; D012749:Sexually Transmitted Diseases / Q000517:prevention & control*; D019966:Substance-Related Disorders
D000900:Anti-Bacterial Agents; D004366:Nonprescription Drugs